GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.

Phase 1

Completed

Conditions: Malaria

First Posted Date: 2005-09-20

Last Posted Date: 2019-12-27

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 200

Registration Number: NCT00197067

Locations: 🇲🇿
GSK Investigational Site, Maputo, Mozambique

Study In Patients With Insulin Resistance

Phase 3

Completed

Conditions: Insulin Resistance

First Posted Date: 2005-09-20

Last Posted Date: 2016-12-05

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 18

Registration Number: NCT00197132

Locations: 🇳🇱
GSK Clinical Trials Call Center, Nijmegen, Netherlands

Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines

Phase 3

Completed

Conditions: Influenza

First Posted Date: 2005-09-20

Last Posted Date: 2017-01-18

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 1847

Registration Number: NCT00197288

Locations: 🇺🇸
GSK Investigational Site, Marshfield, Wisconsin, United States

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

Phase 2

Completed

Conditions: Nausea and Vomiting
Chemotherapy-Induced

First Posted Date: 2005-09-15

Last Posted Date: 2010-05-10

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 492

Registration Number: NCT00169572

Locations: 🇨🇳
GSK Investigational Site, Tao Yuan County, Taiwan

Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.

Phase 4

Completed

Conditions: Asthma

Interventions: Drug: Salmeterol/fluticasone propionate
Drug: Fluticasone propionate

First Posted Date: 2005-09-15

Last Posted Date: 2016-09-15

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 64

Registration Number: NCT00169546

Locations: 🇬🇧
GSK Investigational Site, Manchester, Lancashire, United Kingdom

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Phase 2

Completed

Conditions: Dyslipidaemias

Interventions: Drug: GW590735
Drug: fenofibrate

First Posted Date: 2005-09-15

Last Posted Date: 2012-10-22

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 250

Registration Number: NCT00169559

Locations: 🇨🇦
GSK Investigational Site, Sainte-Foy, Quebec, Canada

Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants

Phase 3

Completed

Conditions: Diphtheria
Tetanus
Haemophilus Influenzae Type b
Hepatitis B
Whole Cell Pertussis

Interventions: Biological: Tritanrix™-HepB/Hiberix™
Biological: Tritanrix™-HepB/Hiberix™ Kft.
Biological: Hiberix™
Biological: Tritanrix™-HepB Kft
Biological: Polyribosil-Ribitol-Phosphate (PRP) vaccine